NCT01630733Phase 3Completed

A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

Study sponsor: Achieve Life Sciences

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2016-11-17Actual
Enrollment · participants664Actual
Source updated2026-04-15Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 6 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Overall Survival. After: Measure: Overall Survival: All Randomized Population Measure: Overall Survival: Stratified by Histology - Squamous vs. Non-Squamous.

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 700 participants (planned). After: 664 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Jul 2017. After: 17 Nov 2016.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source